These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9610757)

  • 1. Indium-111 DTPA-heparin: radiolabeling, pharmacokinetics, and biodistribution following intravenous administration in rat and rabbit.
    Bunting RW; Wilkinson RA; Callahan RJ; Strauss HW; Fischman AJ
    Thromb Res; 1998 Jan; 89(1):23-30. PubMed ID: 9610757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indium-111 DTPA-heparin: pharmacokinetics and biodistribution following subcutaneous administration in rat and rabbit.
    Bunting RW; Wilkinson RA; Callahan RJ; Strauss HW; Fischman AJ
    Thromb Res; 1997 Dec; 88(6):503-7. PubMed ID: 9610962
    [No Abstract]   [Full Text] [Related]  

  • 3. Inducing a change in the pharmacokinetics and biodistribution of poly-L-lysine in rats by complexation with heparin.
    Johnston TP; Kuchimanchi KR; Alur H; Chittchang M; Mitra AK
    J Pharm Pharmacol; 2003 Aug; 55(8):1083-90. PubMed ID: 12956897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical pharmacokinetic, biodistribution, toxicology, and dosimetry studies of 111In-DTPA-human epidermal growth factor: an auger electron-emitting radiotherapeutic agent for epidermal growth factor receptor-positive breast cancer.
    Reilly RM; Chen P; Wang J; Scollard D; Cameron R; Vallis KA
    J Nucl Med; 2006 Jun; 47(6):1023-31. PubMed ID: 16741313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody.
    Kobayashi H; Wu C; Kim MK; Paik CH; Carrasquillo JA; Brechbiel MW
    Bioconjug Chem; 1999; 10(1):103-11. PubMed ID: 9893971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The addition of DTPA to [177Lu-DOTA0,Tyr3]octreotate prior to administration reduces rat skeleton uptake of radioactivity.
    Breeman WA; van der Wansem K; Bernard BF; van Gameren A; Erion JL; Visser TJ; Krenning EP; de Jong M
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):312-5. PubMed ID: 12552352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of heparin and low molecular weight heparin fragment (Fragmin) in rabbits with impaired renal or metabolic clearance.
    Palm M; Mattsson C
    Thromb Haemost; 1987 Oct; 58(3):932-5. PubMed ID: 2829379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution and elimination characteristics of 111In-DTPA-D-phe1-octreotide and 111In-DTPA-L-phe1-octreotide in rats.
    Laznickova A; Laznicek M; Trejtnar F; Melicharova L; Suzuki KH; Akizawa H; Arano Y; Yokoyama A
    Eur J Drug Metab Pharmacokinet; 2002; 27(1):37-43. PubMed ID: 11996325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of [111In-DTPA0]octreotide in the rat kidney is inhibited by colchicine and not by fructose.
    Rolleman EJ; Krenning EP; Van Gameren A; Bernard BF; De Jong M
    J Nucl Med; 2004 Apr; 45(4):709-13. PubMed ID: 15073269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of (111)In(3+) complexes of DTPA amide derivatives: biodistribution and clearance studied by gamma imaging.
    Prata MI; Santos AC; Bligh SW; Chowdhury AH; Geraldes CF; de Lima JJ
    Nucl Med Biol; 2000 Aug; 27(6):605-10. PubMed ID: 11056377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusion of hIgG1-Fc to 111In-anti-amyloid single domain antibody fragment VHH-pa2H prolongs blood residential time in APP/PS1 mice but does not increase brain uptake.
    Rotman M; Welling MM; van den Boogaard ML; Moursel LG; van der Graaf LM; van Buchem MA; van der Maarel SM; van der Weerd L
    Nucl Med Biol; 2015 Aug; 42(8):695-702. PubMed ID: 25960433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake.
    Bernard BF; Krenning EP; Breeman WA; Rolleman EJ; Bakker WH; Visser TJ; Mäcke H; de Jong M
    J Nucl Med; 1997 Dec; 38(12):1929-33. PubMed ID: 9430472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer.
    de Visser M; Janssen PJ; Srinivasan A; Reubi JC; Waser B; Erion JL; Schmidt MA; Krenning EP; de Jong M
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1134-9. PubMed ID: 12768332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo comparison of DTPA- and DOTA-conjugated antiferritin monoclonal antibody for imaging and therapy of pancreatic cancer.
    Sabbah EN; Kadouche J; Ellison D; Finucane C; Decaudin D; Mather SJ
    Nucl Med Biol; 2007 Apr; 34(3):293-304. PubMed ID: 17383579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of [99mTc/EDDA/HYNIC0]octreotide derivatives compared with [111In-DOTA0,Tyr3, Thr8]octreotide and [111In-DTPA0]octreotide: does tumor or pancreas uptake correlate with the rate of internalization?
    Storch D; Béhé M; Walter MA; Chen J; Powell P; Mikolajczak R; Mäcke HR
    J Nucl Med; 2005 Sep; 46(9):1561-9. PubMed ID: 16157541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue distribution, circulating half-life, and excretion of intravenously administered protamine sulfate.
    DeLucia A; Wakefield TW; Kadell AM; Wrobleski SK; VanDort M; Stanley JC
    ASAIO J; 1993; 39(3):M715-8. PubMed ID: 8268631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yttrium-90-labeled human macroaggregated albumin for internal radiotherapy: combined use with DTPA.
    Watanabe N; Oriuchi N; Endo K; Inoue T; Tanada S; Murata H; Sasaki Y
    Nucl Med Biol; 1999 Oct; 26(7):847-51. PubMed ID: 10628567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-clinical evaluation of [(111)In-DTPA-Pro(1), Tyr(4)]bombesin, a new radioligand for bombesin-receptor scintigraphy.
    Breeman WA; De Jong M; Bernard BF; Kwekkeboom DJ; Srinivasan A; van der Pluijm ME; Hofland LJ; Visser TJ; Krenning EP
    Int J Cancer; 1999 Nov; 83(5):657-63. PubMed ID: 10521803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Holmium-166-DTPA as a liquid source for endovascular brachytherapy.
    Hong YD; Park KB; Jang BS; Choi SJ; Choi SM; Kim YM
    Nucl Med Biol; 2002 Nov; 29(8):833-9. PubMed ID: 12453593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of stereochemistry on the clearance mechanism of 111In(III)-labeled D- or L-benzyldiethylenetriaminepentaacetic acid.
    Deal KA; Welch MJ
    J Med Chem; 1997 Nov; 40(24):3986-9. PubMed ID: 9397181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.